Back to trial details

Intake questionnaire

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Applying to South Texas Accelerated Research Therapeutics (START) Midwest · Grand Rapids, Michigan

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Non-small Cell Lung Cancer?
3. Are you able to travel to Grand Rapids for study visits?